Epigenetic Regulation Towards Acquired Drug Resistance in Cancer
- PMID: 36301503
- DOI: 10.1007/978-3-031-07634-3_14
Epigenetic Regulation Towards Acquired Drug Resistance in Cancer
Abstract
Therapy resistance remains the most challenging obstacle in cancer treatment. Substantial efforts and evidences have accumulated over decades suggesting not only genetic but non-genomic mechanisms underlying this adaptation of tumor cells. Alterations in epigenome can have a fundamental effect on cellular functions and response to stresses like anticancer therapy. This chapter discusses the principal mechanisms by which epigenetic modifications in the genome and transcriptome aid tumor cells toward acquisition of resistance to chemotherapy.
Keywords: Cancer; Chemoresistance; Chromatin remodeling; DNA methylation; Epigenetic modification; HDAC; Histone methylation; Histone ubiquitination; lncRNA; miRNA.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Epigenetic inhibitors and their role in cancer therapy.Int Rev Cell Mol Biol. 2023;380:211-251. doi: 10.1016/bs.ircmb.2023.04.005. Epub 2023 Aug 1. Int Rev Cell Mol Biol. 2023. PMID: 37657859
-
Role of Epigenetics for the Efficacy of Cisplatin.Int J Mol Sci. 2024 Jan 17;25(2):1130. doi: 10.3390/ijms25021130. Int J Mol Sci. 2024. PMID: 38256203 Free PMC article. Review.
-
Epigenetically programmed resistance to chemo- and immuno-therapies.Adv Cancer Res. 2023;158:41-71. doi: 10.1016/bs.acr.2022.12.001. Epub 2023 Jan 27. Adv Cancer Res. 2023. PMID: 36990538 Free PMC article.
-
Targeting Chromatin Remodeling for Cancer Therapy.Curr Mol Pharmacol. 2019;12(3):215-229. doi: 10.2174/1874467212666190215112915. Curr Mol Pharmacol. 2019. PMID: 30767757 Free PMC article. Review.
-
Epigenetic reprogramming and potential application of epigenetic-modifying drugs in acquired chemotherapeutic resistance.Adv Clin Chem. 2020;94:219-259. doi: 10.1016/bs.acc.2019.07.011. Epub 2019 Aug 21. Adv Clin Chem. 2020. PMID: 31952572 Review.
Cited by
-
RYBP contributes to improved prognosis in colorectal cancer via regulation of cell cycle, apoptosis and oxaliplatin sensitivity.Int J Oncol. 2023 Nov;63(5):120. doi: 10.3892/ijo.2023.5568. Epub 2023 Sep 1. Int J Oncol. 2023. PMID: 37654197 Free PMC article.
-
Cell death pathways: molecular mechanisms and therapeutic targets for cancer.MedComm (2020). 2024 Sep 4;5(9):e693. doi: 10.1002/mco2.693. eCollection 2024 Sep. MedComm (2020). 2024. PMID: 39239068 Free PMC article. Review.
-
Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers.Cell Death Dis. 2025 Aug 8;16(1):600. doi: 10.1038/s41419-025-07900-w. Cell Death Dis. 2025. PMID: 40781072 Free PMC article.
References
-
- Abe T, Toyota M, Suzuki H, Murai M, Akino K, Ueno M, Nojima M, Yawata A, Miyakawa H, Suga T, Ito H, Endo T, Tokino T, Hinoda Y, Imai K (2005) Upregulation of BNIP3 by 5-aza-2′-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death. Journal of gastroenterology 40(5):504–510. https://doi.org/10.1007/s00535-005-1576-1 - DOI - PubMed
-
- Agarwal R, Chan Y-C, Tam CS, Hunter T, Vassiliadis D, Teh CE, Thijssen R, Yeh P, Wong SQ, Ftouni S, Lam EYN, Anderson MA, Pott C, Gilan O, Bell CC, Knezevic K, Blombery P, Rayeroux K, Zordan A, Li J, Huang DCS, Wall M, Seymour JF, Gray DHD, Roberts AW, Dawson MA, Dawson S-J (2019) Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma. Nature Medicine 25(1):119–129. https://doi.org/10.1038/s41591-018-0243-z - DOI - PubMed
-
- Allfrey VG, Mirsky AE (1964) Structural modifications of histones and their possible role in the regulation of RNA synthesis., J Sci 144(3618):559–559. https://doi.org/10.1126/science.144.3618.559
-
- Allfrey VG, Faulkner R, Mirsky AE (1964) Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Nat Acad Sci U S A 51(5):786–794. https://doi.org/10.1073/pnas.51.5.786 - DOI
-
- Angelucci A, Mari M, Millimaggi D, Giusti I, Carta G, Bologna M, Dolo V (2010) Suberoylanilide hydroxamic acid partly reverses resistance to paclitaxel in human ovarian cancer cell lines. Gynecol Oncol 119(3):557–563. https://doi.org/10.1016/j.ygyno.2010.07.036 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical